Strategic Communication for Hormonal Contraception and HIV: An Evidence Review

This article developed by Breakthrough ACTION provides an overview of the evidence to date guiding communication around the potential risks of HIV acquisition associated with progestogen-only injectables, and the background to the development of the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-Related Risks.

Last modified: March 25, 2019

Language: English